Scienture (SCNX) Stock: Why It's Up Today
Updated Oct 20, 2026, 1:16 PM ET · intraday price
- Trading at $2.99 as of 1:16 PM ET, +2.36% vs the prior close of $2.92.
- Volume 12.46K shares, 0.1x its 50-day average (light).
- New SEC filings: 8-K (Oct 19, 2026).
- No new insider buys or sales reported since the prior session.
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Pfizer (PFE)
SCNX rises 2.4% to $2.99. Trading at $2.99 (intraday, 1:16 PM ET), +2.36% vs the prior close of $2.92. Day range $2.92–$3.03, opened at $2.99.
SCNX daily analysis — what happened
A plain-English, data-only note for every US trading day (today's note updates every 2 hours while the market is open). Newest first; older days stay archived below.
Oct 20, 2026 — SCNX rises 2.4% to $2.99
- Trading at $2.99 (intraday, 1:16 PM ET), +2.36% vs the prior close of $2.92. Day range $2.92–$3.03, opened at $2.99.
- Volume was 12.46K shares, 0.1x its 50-day average of 240.41K — lighter than usual.
- Price is -61.0% vs its 50-day average ($7.66) and -68.9% vs its 200-day average ($9.60).
- 52-week range $2.81–$65.00; the current price sits at 0% of that range, 95.4% below the 52-week high.
Oct 19, 2026 — SCNX slides 13.1% to $2.92, a 52-week low
- Closed at $2.92, -13.10% vs the prior close of $3.36. Day range $2.81–$3.39, opened at $3.39.
- Volume was 75.41K shares, 0.3x its 50-day average of 238.99K — lighter than usual.
- Price is -62.6% vs its 50-day average ($7.81) and -69.7% vs its 200-day average ($9.65).
- 52-week range $2.81–$65.00; today's close sits at 0% of that range, 95.5% below the 52-week high.
Oct 16, 2026 — SCNX dips 0.6% to $3.36
- Closed at $3.36, -0.59% vs the prior close of $3.38. Day range $3.25–$3.42, opened at $3.27.
- Volume was 24.14K shares, 0.1x its 50-day average of 238.71K — lighter than usual.
- Price is -57.7% vs its 50-day average ($7.94) and -65.3% vs its 200-day average ($9.70).
- 52-week range $3.21–$65.00; today's close sits at 0% of that range, 94.8% below the 52-week high.
Oct 15, 2026 — SCNX rises 0.9% to $3.38
- Closed at $3.38, +0.90% vs the prior close of $3.35. Day range $3.21–$3.68, opened at $3.68.
- Volume was 52.60K shares, 0.2x its 50-day average of 237.83K — lighter than usual.
- Price is -58.0% vs its 50-day average ($8.06) and -65.3% vs its 200-day average ($9.74).
- 52-week range $3.21–$65.00; today's close sits at 0% of that range, 94.8% below the 52-week high.
Oct 14, 2026 — SCNX jumps 3.4% to $3.35
- Closed at $3.35, +3.40% vs the prior close of $3.24. Day range $3.27–$3.52, opened at $3.33.
- Volume was 38.60K shares, 0.2x its 50-day average of 237.29K — lighter than usual.
- Price is -59.1% vs its 50-day average ($8.18) and -65.8% vs its 200-day average ($9.79).
- 52-week range $3.23–$65.00; today's close sits at 0% of that range, 94.8% below the 52-week high.
Oct 13, 2026 — SCNX slides 17.1% to $3.24, a 52-week low on 2.0x normal volume
- Closed at $3.24, -17.14% vs the prior close of $3.91. Day range $3.24–$3.93, opened at $3.93.
- Volume was 464.40K shares, 2.0x its 50-day average of 228.14K — unusually heavy trading.
- Price is -61.0% vs its 50-day average ($8.30) and -67.1% vs its 200-day average ($9.84).
- 52-week range $3.23–$65.00; today's close sits at 0% of that range, 95.0% below the 52-week high.
Oct 12, 2026 — SCNX jumps 4.0% to $3.91
- Closed at $3.91, +3.99% vs the prior close of $3.76. Day range $3.58–$3.91, opened at $3.79.
- Volume was 37.60K shares, 0.2x its 50-day average of 227.49K — lighter than usual.
- Price is -53.6% vs its 50-day average ($8.43) and -60.4% vs its 200-day average ($9.89).
- 52-week range $3.23–$65.00; today's close sits at 1% of that range, 94.0% below the 52-week high.
Oct 9, 2026 — SCNX dips 2.6% to $3.76
- Closed at $3.76, -2.59% vs the prior close of $3.86. Day range $3.65–$3.84, opened at $3.79.
- Volume was 32.00K shares, 0.1x its 50-day average of 227.08K — lighter than usual.
- Price is -56.0% vs its 50-day average ($8.55) and -62.2% vs its 200-day average ($9.94).
- 52-week range $3.23–$65.00; today's close sits at 1% of that range, 94.2% below the 52-week high.
Oct 8, 2026 — SCNX slides 6.5% to $3.86
- Closed at $3.86, -6.54% vs the prior close of $4.13. Day range $3.76–$4.26, opened at $4.26.
- Volume was 70.70K shares, 0.3x its 50-day average of 225.82K — lighter than usual.
- Price is -55.4% vs its 50-day average ($8.66) and -61.3% vs its 200-day average ($9.99).
- 52-week range $3.23–$65.00; today's close sits at 1% of that range, 94.1% below the 52-week high.
Oct 7, 2026 — SCNX jumps 9.8% to $4.13
- Closed at $4.13, +9.84% vs the prior close of $3.76. Day range $3.65–$4.20, opened at $3.85.
- Volume was 106.80K shares, 0.5x its 50-day average of 223.84K — lighter than usual.
- Price is -52.9% vs its 50-day average ($8.77) and -58.9% vs its 200-day average ($10.04).
- 52-week range $3.23–$65.00; today's close sits at 1% of that range, 93.6% below the 52-week high.
- SEC filings that day: 8-K.
Oct 6, 2026 — SCNX rises 1.3% to $3.76
- Closed at $3.76, +1.35% vs the prior close of $3.71. Day range $3.23–$4.14, opened at $3.23.
- Volume was 214.80K shares, 1.0x its 50-day average of 219.93K.
- Price is -57.6% vs its 50-day average ($8.87) and -62.7% vs its 200-day average ($10.08).
- 52-week range $3.23–$65.00; today's close sits at 1% of that range, 94.2% below the 52-week high.
Oct 5, 2026 — SCNX slides 6.7% to $3.71, a 52-week low, 8 down days in a row
- Closed at $3.71, -6.67% vs the prior close of $3.97. Day range $3.56–$4.25, opened at $3.89.
- Volume was 245.20K shares, 1.1x its 50-day average of 215.26K.
- Price is -58.7% vs its 50-day average ($8.98) and -63.3% vs its 200-day average ($10.12).
- 52-week range $3.35–$65.00; today's close sits at 1% of that range, 94.3% below the 52-week high.
- That makes 8 straight losses.
Oct 2, 2026 — SCNX slides 10.2% to $3.97, a 52-week low on 77.2x normal volume
- Closed at $3.97, -10.17% vs the prior close of $4.43. Day range $3.35–$5.35, opened at $5.28.
- Volume was 6.54M shares, 77.2x its 50-day average of 84.70K — unusually heavy trading.
- Price is -56.3% vs its 50-day average ($9.09) and -60.9% vs its 200-day average ($10.17).
- 52-week range $3.35–$65.00; today's close sits at 1% of that range, 93.9% below the 52-week high.
- That makes 7 straight losses.
SCNX bull case vs bear case (from the data)
- Annual revenue grew 215.9% in the latest fiscal year (SEC XBRL).
- Price is -61.0% vs its 50-day average — short-term trend is down.
- Price is -68.9% vs its 200-day average — below the long-term trend line.
- Latest fiscal-year net income: loss of $41.51M.
- Share count up 154.6% in a year (dilution).
- High volatility: average daily move of 6.2% over 20 sessions.
- Thin trading (under $2M a day on average) can mean wide bid/ask spreads.
SCNX latest news & SEC filings
Every SEC filing by or about SCNX in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 19, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
- Item 3.01 — Stock exchange listing notice or transfer of listing.
This is a results-day filing: the earnings press release is attached as an exhibit.
Oct 7, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.03 — Change to shareholder rights.
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 18, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Sep 14, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 8, 2026 · Form PRE 14A — Preliminary proxy statement
Preliminary proxy statement
Aug 31, 2026 · Form 5 — Annual insider statement
Annual insider ownership statement (Form 5)
Aug 31, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Aug 20, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Aug 13, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $343.64K
- Net income: -$2.82M (prior year -$6.72M) (loss narrowed vs Jun 30, 2025)
- Diluted EPS: -$0.07 (prior year -$0.48) (loss narrowed vs Jun 30, 2025)
Things to know before you trade SCNX
- Last results release: Oct 19, 2026 (8-K Item 2.02). Previous ones: Aug 20, 2026, May 22, 2026, May 15, 2023. Based on that rhythm, the next report is likely around Jan 18, 2027 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 6.15% (largest 31.9%). That is a volatile stock.
- Liquidity: about 405.85K shares (≈$1.21M) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $2.99 vs a range of $2.81–$65.00 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:25 on Oct 5, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Oct 19, 2026; 8-K Oct 7, 2026; 8-K Sep 14, 2026.
- Share count: 41.06M shares outstanding (Aug 13, 2026), +154.6% vs a year earlier — notable dilution.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
SCNX market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 20, 2026 | 2.99 | 3.03 | 2.92 | 2.99 | 12.46K |
| Oct 19, 2026 | 3.39 | 3.39 | 2.81 | 2.92 | 75.50K |
| Oct 16, 2026 | 3.38 | 3.42 | 3.25 | 3.36 | 24.10K |
| Oct 15, 2026 | 3.68 | 3.68 | 3.21 | 3.38 | 52.60K |
| Oct 14, 2026 | 3.33 | 3.52 | 3.27 | 3.35 | 38.60K |
| Oct 13, 2026 | 3.93 | 3.93 | 3.24 | 3.24 | 464.40K |
| Oct 12, 2026 | 3.79 | 3.91 | 3.58 | 3.91 | 37.60K |
| Oct 9, 2026 | 3.79 | 3.84 | 3.65 | 3.76 | 32.00K |
| Oct 8, 2026 | 4.26 | 4.26 | 3.76 | 3.86 | 70.70K |
| Oct 7, 2026 | 3.85 | 4.20 | 3.65 | 4.13 | 106.80K |
| Oct 6, 2026 | 3.23 | 4.14 | 3.23 | 3.76 | 214.80K |
| Oct 5, 2026 | 3.89 | 4.25 | 3.56 | 3.71 | 245.20K |
| Oct 2, 2026 | 5.28 | 5.35 | 3.35 | 3.97 | 6.54M |
| Oct 1, 2026 | 5.15 | 5.15 | 4.40 | 4.43 | 77.34K |
| Sep 30, 2026 | 6.68 | 6.78 | 6.30 | 6.50 | 25.33K |
| Sep 29, 2026 | 6.60 | 6.85 | 6.50 | 6.68 | 15.10K |
| Sep 28, 2026 | 6.78 | 6.90 | 6.50 | 6.75 | 15.88K |
| Sep 25, 2026 | 7.00 | 7.25 | 6.75 | 6.93 | 16.55K |
| Sep 24, 2026 | 7.03 | 7.25 | 6.97 | 7.18 | 12.30K |
| Sep 23, 2026 | 7.05 | 7.28 | 6.95 | 7.25 | 44.21K |
About Scienture
Scienture (SCNX) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in COMMACK, NY. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1382574.
SCNX board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Mani Narasimhan | President & Co-CEO | Mar 12, 2026 |
| Hariharan Shankar | Co-CEO & Chairman | Mar 12, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Mani Narasimhan | President & Co-CEO | Mar 12, 2026 |
| Hariharan Shankar | Co-CEO & Chairman | Mar 12, 2026 |
| Eric Michael Sherb | Chief Financial Officer | Aug 31, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
SCNX financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $431.61K | $-41.51M | -2.70 | $-13.38M |
| Dec 31, 2024 | $136.64K | $9.07M | 2.48 | $-14.27M |
| Dec 31, 2023 | $1.36M | $-17.84M | -23.35 | $-2.23M |
| Dec 31, 2022 | $10.25M | $-3.47M | -6.13 | $-1.53M |
| Dec 31, 2021 | $9.89M | $-5.32M | -0.65 | $-2.57M |
Latest balance sheet: total assets $87.73M, total liabilities $23.63M, cash $8.19M (as of Jun 30, 2026).
SCNX earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Oct 19, 2026 | 8-K Item 2.02 (results) | $2.92 |
| Aug 20, 2026 | 8-K Item 2.02 (results) | $11.80 |
| May 22, 2026 | 8-K Item 2.02 (results) | $10.05 |
| May 15, 2023 | 8-K Item 2.02 (results) | — |
| Mar 27, 2023 | 8-K Item 2.02 (results) | — |
| Nov 7, 2022 | 8-K Item 2.02 (results) | — |
| Jul 25, 2022 | 8-K Item 2.02 (results) | — |
| May 9, 2022 | 8-K Item 2.02 (results) | — |
| Mar 28, 2022 | 8-K Item 2.02 (results) | — |
| Oct 25, 2021 | 8-K Item 2.02 (results) | — |
| Jul 26, 2021 | 8-K Item 2.02 (results) | — |
| Apr 26, 2021 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)AbbVie (ABBV)Merck (MRK)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Regeneron Pharmaceuticals (REGN)United Therapeutics (UTHR)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Space Exploration Technologies (SPCX)Tesla (TSLA)Sandisk (SNDK)Apple (AAPL)AMD (AMD)Microsoft (MSFT)Intel (INTC)Amazon (AMZN)
More on SCNX
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: intraday data as of Oct 20, 2026, 1:16 PM ET. Filings: SEC EDGAR. Refreshed every 2 hours during US market hours.